ID

20308

Description

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Visit 1 (Month 0) Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Lien

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Mots-clés

Versions (2)
  1. 15/02/2017 15/02/2017 -
  2. 20/02/2017 20/02/2017 -
Téléchargé le

20 février 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Anglais

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulaires  
Toast Criteria
Description

Toast Criteria

Alias
UMLS CUI-1
C1710306
For the qualifying stroke, please categories the etiologic subtype below (indicate one only)
Description

Etiologic subtype

Type de données

integer

Alias
UMLS CUI [1,1]
C0038454
UMLS CUI [1,2]
C0015127
Concomitant Medication
Description

Concomitant Medication

Alias
UMLS CUI-1
C2347852
Are any medications listed below currently being taken on the day of visit 1?
Description

Medication taken

Type de données

boolean

Alias
UMLS CUI [1]
C1553892
If yes, please indicate which, if any, of the following are currently being taken:
Description

If the patient is taking any restricted (bolded) concomitant medications (see facing page), please ensure these are stopped prior to randomasation.

Type de données

integer

Alias
UMLS CUI [1]
C1553892
ACE Inhibitors
Description

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
Are ACE Inhibitors currently being taken on the day of visit 1?
Description

ACE Inhibitors currently taken

Type de données

boolean

Alias
UMLS CUI [1]
C0013227
Name of ACE Inhibitor and Total Daily Dose
Description

Name of ACE Inhibitor and Total Daily Dose

Type de données

text

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C2360065
UMLS CUI [2,1]
C0003015
UMLS CUI [2,2]
C2348070
Retour au début de la page

Similar models

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Toast Criteria
C1710306 (UMLS CUI-1)
Item
For the qualifying stroke, please categories the etiologic subtype below (indicate one only)
integer
C0038454 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
Etiologic subtype
Code List
For the qualifying stroke, please categories the etiologic subtype below (indicate one only)
CL Item
Large-artery atherosclerosis (1)
CL Item
Cardioembolism (2)
CL Item
Small-artery occlusion (lacune) (3)
CL Item
Acute stroke of other determined etiology (4)
CL Item
Stroke of underdetermined etiology (5)
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Medication taken
Item
Are any medications listed below currently being taken on the day of visit 1?
boolean
C1553892 (UMLS CUI [1])
Item
If yes, please indicate which, if any, of the following are currently being taken:
integer
C1553892 (UMLS CUI [1])
If yes, please indicate which
Code List
If yes, please indicate which, if any, of the following are currently being taken:
CL Item
Dipyridamole (0)
CL Item
Aspirin (1)
CL Item
Ticlopidine (2)
CL Item
Clopidogrel (3)
CL Item
Aspirin/extended release Dipyridamole (4)
CL Item
Oral anticoagulants (5)
CL Item
Nitrates (oral or topical) (6)
CL Item
Estrogen replacement without progesterone (7)
CL Item
Estrogen replacement with progesterone (8)
CL Item
Digitalis (9)
CL Item
Statins (10)
CL Item
Fibrates (11)
CL Item
Dilitazem/Verapamil (12)
CL Item
Other calcium channel blockers (13)
CL Item
Alpha-blocker (14)
CL Item
Direct vasodilators (15)
CL Item
Angiotensin Receptor Blocker (ARB) (16)
CL Item
Peripheral sympatholytic (17)
CL Item
Central sympatholytic (18)
CL Item
Alpha-beta blocker (19)
CL Item
Beta-blocker (20)
CL Item
Loop-active diuretics (21)
CL Item
Diuretics of thiazide type (22)
CL Item
Potassium-sparing diuretics (23)
CL Item
Insulin (24)
CL Item
Oral hypoglycemic agents (25)
CL Item
Non-steroidal anti-inflammatory drugs (26)
CL Item
Specific Cox II inhibitors (27)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
Are ACE Inhibitors currently being taken on the day of visit 1?
boolean
C0013227 (UMLS CUI [1])
Name of ACE Inhibitor and Total Daily Dose
Item
Name of ACE Inhibitor and Total Daily Dose
text
C0003015 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
C0003015 (UMLS CUI [2,1])
C2348070 (UMLS CUI [2,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial